Froebe C L, Simion F A, Rhein L D, Cagan R H, Kligman A
Colgate-Palmolive Co., Piscataway, N.J.
Dermatologica. 1990;181(4):277-83. doi: 10.1159/000247822.
The relationship between the in vivo irritation potential of sodium lauryl sulfate (SLS) and linear alkyl benzene sulfonate (LAS) and the ability of these two surfactants to remove lipid from the stratum corneum (SC) in vitro were investigated. Either surfactant removes detectable levels of lipids only above its critical micelle concentration (CMC). At high concentrations the surfactants removed only very small amounts of cholesterol, free fatty acid, the esters of those materials, and possibly squalene. SLS and LAS have been shown, below the CMC, to bind to and irritate the SC. Thus, clinical irritation provoked by SLS or LAS is unlikely to be directly linked with extraction of SC lipid. The milder forms of irritation--dryness, tightness, roughness--may involve both surfactant binding to and denaturation of keratin as well as disruption of lipid. Our findings challenge earlier assumptions that surfactants' degreasing of the SC is involved in the induction of erythema.
研究了月桂醇硫酸酯钠(SLS)和直链烷基苯磺酸盐(LAS)在体内的刺激潜力与这两种表面活性剂在体外从角质层(SC)去除脂质的能力之间的关系。两种表面活性剂均仅在其临界胶束浓度(CMC)以上才能去除可检测水平的脂质。在高浓度下,表面活性剂仅去除极少量的胆固醇、游离脂肪酸、这些物质的酯以及可能的角鲨烯。已表明,在CMC以下,SLS和LAS会与SC结合并对其产生刺激。因此,SLS或LAS引起的临床刺激不太可能与SC脂质的提取直接相关。较轻微的刺激形式——干燥、紧绷、粗糙——可能涉及表面活性剂与角蛋白的结合和变性以及脂质的破坏。我们的研究结果挑战了早期的假设,即表面活性剂对SC的脱脂作用与红斑的诱导有关。